Organization profile

Organisation profile

The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.

Fingerprint Dive into the research topics where RCCTM - Translational medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Chondrosarcoma Medicine & Life Sciences
Osteoclasts Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Paeonia Medicine & Life Sciences
HMGB1 Protein Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Thalassemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2018

新聘教師研究補助

Tzeng, H.

10/1/179/30/18

Project: B - Project of TMUg - Research Grants for Newly Hired Faculty

Research Output 2014 2018

  • 32 Citations
  • 3 h-Index
  • 8 Article
3 Citations (Scopus)

CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma

Tzeng, H. E., Tang, C. H., Wu, S. H., Chen, H. T., Fong, Y. C., Lu, Y. C., Chen, W. C., Huang, H. D., Lin, C. Y. & Wang, S. W., Oct 1 2018, In : Cell Death and Disease. 9, 10, 955.

Research output: Contribution to journalArticle

Chondrosarcoma
Metalloproteases
Neoplasm Metastasis
S 10
Cell Movement
2 Citations (Scopus)

Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer

Hu, G. N., Tzeng, H. E., Chen, P. C., Wang, C. Q., Zhao, Y. M., Wang, Y., Su, C. M. & Tang, C. H., Jul 30 2018, In : International Journal of Medical Sciences. 15, 11, p. 1179-1186 8 p.

Research output: Contribution to journalArticle

Single Nucleotide Polymorphism
Breast Neoplasms
Genotype
Genes
Neoplasm Metastasis
6 Citations (Scopus)

HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer

Huang, B. F., Tzeng, H. E., Chen, P. C., Wang, C. Q., Su, C. M., Wang, Y., Hu, G. N., Zhao, Y. M., Wang, Q. & Tang, C. H., Mar 12 2018, In : International Journal of Medical Sciences. 15, 6, p. 580-586 7 p.

Research output: Contribution to journalArticle

HMGB1 Protein
Genetic Polymorphisms
Biomarkers
Breast Neoplasms
Triple Negative Breast Neoplasms